Titre : | Is Vancouver Canada's supervised injection facility cost-saving? (2010) |
Auteurs : | S. D. PINKERTON |
Type de document : | Article : Périodique |
Dans : | Addiction (Vol.105, n°8, August 2010) |
Article en page(s) : | 1429-1436 |
Langues: | Anglais |
Discipline : | SAN (Santé publique / Public health) |
Mots-clés : |
Thésaurus mots-clés SALLE DE CONSOMMATION A MOINDRE RISQUE ; REDUCTION DE CONSOMMATION ; MODELE STATISTIQUE ; VIH ; INFECTION ; COUT ; EFFICACITE ; ECHANGE DE SERINGUESThésaurus géographique CANADA |
Résumé : |
OBJECTIVE: To determine whether Vancouver's Insite supervised injection facility and syringe exchange programs are cost-saving--that is, are the savings due to averted HIV-related medical care costs sufficient to offset Insite's operating costs?
METHODS: The analyses examined the impact of Insite's programs for a single year. Mathematical models were used to calculate the number of additional HIV infections that would be expected if Insite were closed. The life-time HIV-related medical costs associated with these additional infections were compared to the annual operating costs of the Insite facility. RESULTS: If Insite were closed, the annual number of incident HIV infections among Vancouver IDU would be expected to increase from 179.3 to 262.8. These 83.5 preventable infections are associated with $17.6 million (Canadian) in life-time HIV-related medical care costs, greatly exceeding Insite's operating costs, which are approximately $3 million per year. CONCLUSIONS: Insite's safe injection facility and syringe exchange program substantially reduce the incidence of HIV infection within Vancouver's IDU community. The associated savings in averted HIV-related medical care costs are more than sufficient to offset Insite's operating costs. |
Domaine : | Drogues illicites / Illicit drugs |
Affiliation : | Center for AIDS Intervention Research, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, WI, USA |
Cote : | Abonnement |
Accueil